Literature DB >> 2375247

Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.

E Martignoni1, F Petraglia, A Costa, G Bono, A R Genazzani, G Nappi.   

Abstract

The activity of the hypothalamus-pituitary-adrenocortical (HPA) axis was explored in 10 patients with dementia of the Alzheimer type (DAT) and in 11 age-matched controls, by measuring 1) corticotropin-releasing factor (CRF) levels in cerebrospinal fluid (CSF), 2) the circadian changes of plasma cortisol, 3) and 4) the plasma cortisol response to dexamethasone suppression test (DST) and to CRF stimulation test. CSF CRF levels in DAT were significantly higher than in controls and inversely related to the Mini Mental State (MMS) score. The patients also displayed increased morning (0800 h) plasma cortisol values, with higher mesor and amplitude in the circadian pattern. Dexamethasone resistance was shown by 6 of the 10 DAT subjects. Plasma cortisol response to CRF administration was similar in the two groups, except for the peak values, which in DAT patients were reached earlier than in controls. The present data suggest an overactivity of HPA axis in DAT; its possible role in the evolution of the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375247     DOI: 10.1111/j.1600-0404.1990.tb00994.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.

Authors:  C Mondadori; C Gentsch; B Hengerer; T Ducret; J Borkowski; A Racine; R Lederer; A Haeusler
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.

Authors:  Benoit Lehallier; Laurent Essioux; Javier Gayan; Roxana Alexandridis; Tania Nikolcheva; Tony Wyss-Coray; Markus Britschgi
Journal:  JAMA Neurol       Date:  2015-12-14       Impact factor: 18.302

3.  Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Authors:  Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W Eschweiler; Thomas Leyhe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

Review 4.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

5.  Reversal of cycloheximide-induced memory disruption by AIT-082 (Neotrofin) is modulated by, but not dependent on, adrenal hormones.

Authors:  Rongzi Yan; Quang Nguyen; James Gonzaga; Mai Johnson; Ronald F Ritzmann; Eve M Taylor
Journal:  Psychopharmacology (Berl)       Date:  2003-02-26       Impact factor: 4.530

6.  Effect of infection with the 139H scrapie strain on the number, area and/or location of hypothalamic CRF- and VP-immunostained neurons.

Authors:  X Ye; R I Carp; Y Yu; R Kozielski; P Kozlowski
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics.

Authors:  C Mondadori; T Ducret; A Häusler
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients.

Authors:  G Murialdo; A Barreca; F Nobili; A Rollero; G Timossi; M V Gianelli; F Copello; G Rodriguez; A Polleri
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 5.467

Review 9.  Experimental animal models for the simulation of depression and anxiety.

Authors:  Eberhard Fuchs; Gabriele Flïugge
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

Review 10.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.